CMMB

Chemomab Therapeutics

12 hedge funds and large institutions have $58.7M invested in Chemomab Therapeutics in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$5.53M
2 +$1.21M
3 +$837K
4
MIH
Meitav Investment House
Israel
+$615K
5
VF
Virtu Financial
New York
+$251K

Top Sellers

1 -$3.63M
2 -$2.69M
3 -$202K
4
BFM
Boothbay Fund Management
New York
-$134K
5
UBS Group
UBS Group
Switzerland
-$14.9K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$49M
2
$5.53M
3
$1.21M
4
$1.04M
5
$837K
6
$773K
7
$251K
8
$10K
9
$3K
10
$3K
11
$1K
12
13
14
15